On the public citation graph

Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia

https://doi.org/10.1007/s10620-021-07149-1

0 signed · 66 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s00535-018-1476-9openalex-snapshot

Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis

inferredcites →https://doi.org/10.1007/s10620-017-4599-6openalex-snapshot

The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting

inferredcites →https://doi.org/10.1007/s10620-017-4674-zopenalex-snapshot

Erratum to: The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting

inferredcites →https://doi.org/10.1007/s10620-018-5343-6openalex-snapshot

Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors

inferredcites →https://doi.org/10.1007/s11938-018-0207-xopenalex-snapshot

Gastroduodenal “Dysbiosis”: a New Clinical Entity

inferredcites →https://doi.org/10.1016/b978-0-323-54843-4.00006-4openalex-snapshot

Clinical Conditions Associated With Bacterial Overgrowth

inferredcites →https://doi.org/10.1038/ctg.2016.32openalex-snapshot

Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome

inferredcites →https://doi.org/10.1053/j.gastro.2005.11.059openalex-snapshot

Functional Gastroduodenal Disorders

inferredcites →https://doi.org/10.1053/j.gastro.2005.11.061openalex-snapshot

Functional Bowel Disorders

inferredcites →https://doi.org/10.1053/j.gastro.2013.10.026openalex-snapshot

Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats

inferredcites →https://doi.org/10.1053/j.gastro.2016.02.011openalex-snapshot

Gastroduodenal Disorders

inferredcites →https://doi.org/10.1053/j.gastro.2016.02.032openalex-snapshot

Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV

inferredcites →https://doi.org/10.1053/j.gastro.2016.03.035openalex-snapshot

Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction

inferredcites →https://doi.org/10.1053/j.gastro.2016.09.049openalex-snapshot

Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome

inferredcites →https://doi.org/10.1055/s-0037-1608832openalex-snapshot

Systematic Review and Meta-Analysis: Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Liver Disease

inferredcites →https://doi.org/10.1056/nejmoa1004409openalex-snapshot

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

inferredcites →https://doi.org/10.1097/mcg.0b013e3181c64c90openalex-snapshot

A Combination of Rifaximin and Neomycin Is Most Effective in Treating Irritable Bowel Syndrome Patients With Methane on Lactulose Breath Test

inferredcites →https://doi.org/10.1111/apt.12479openalex-snapshot

Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth

inferredcites →https://doi.org/10.1111/apt.13945openalex-snapshot

Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia

inferredcites →https://doi.org/10.1111/apt.15133openalex-snapshot

Systematic review with meta‐analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease

inferredcites →https://doi.org/10.1111/apt.15786openalex-snapshot

Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease

inferredcites →https://doi.org/10.1111/j.1365-2982.2009.01415.xopenalex-snapshot

Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia?

inferredcites →https://doi.org/10.1111/j.1572-0241.2008.01992.xopenalex-snapshot

Bacterial Overgrowth and Irritable Bowel Syndrome: Unifying Hypothesis or a Spurious Consequence of Proton Pump Inhibitors?

inferredcites →https://doi.org/10.1136/gut.2003.030049openalex-snapshot

Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters

inferredcites →https://doi.org/10.1136/gut.42.6.814openalex-snapshot

Symptoms and visceral perception in severe functional and organic dyspepsia

inferredcites →https://doi.org/10.1136/gutjnl-2016-312361openalex-snapshot

Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts

inferredcites →https://doi.org/10.1136/gutjnl-2016-312574openalex-snapshot

Dyspepsia and the microbiome: time to focus on the small intestine

inferredcites →https://doi.org/10.1159/000485409openalex-snapshot

Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview

inferredcites →https://doi.org/10.14309/ajg.0000000000000444openalex-snapshot

Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea

inferredcites →https://doi.org/10.14309/ajg.0000000000000504openalex-snapshot

Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies

inferredcites →https://doi.org/10.14309/ajg.0000000000001197openalex-snapshot

Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis

inferredcites →https://doi.org/10.5056/jnm.2011.17.3.279openalex-snapshot

Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4074669openalex-extracted

Small Intestinal Bacterial Overgrowth Complicating Gastrointestinal Manifestations of Systemic Sclerosis: A Systematic Review and Meta-Analysis

inferred← citeshttps://doi.org/10.1002/ueg2.12164openalex-snapshot

Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders

inferred← citeshttps://doi.org/10.1007/978-3-031-46712-7_6openalex-snapshot

The Role of Gut Bacteria in Functional Gastrointestinal Disorders

inferred← citeshttps://doi.org/10.1007/978-3-662-68455-9_9openalex-snapshot

Rolle des gastrointestinalen Mikrobioms bei Erkrankungen der Darm-Hirn-Achse

inferred← citeshttps://doi.org/10.1007/s10620-021-07155-3openalex-snapshot

Functional Disease, Dysbiosis, and Dyspepsia: How Helpful Is Rifaximin?

inferred← citeshttps://doi.org/10.1007/s12664-021-01235-yopenalex-snapshot

Small intestinal bacterial overgrowth in inflammatory bowel disease

inferred← citeshttps://doi.org/10.1007/s12664-022-01292-xopenalex-snapshot

Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association

inferred← citeshttps://doi.org/10.1007/s40265-021-01634-7openalex-snapshot

Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options

inferred← citeshttps://doi.org/10.1007/s43440-026-00830-0openalex-snapshot

Rifaximin’s therapeutic spectrum: approved indications and experimental insights into emerging uses

inferred← citeshttps://doi.org/10.1016/j.dld.2024.05.004openalex-snapshot

Microbiota modulation in disorders of gut-brain interaction

inferred← citeshttps://doi.org/10.1016/j.dld.2025.07.010openalex-snapshot

Mechanisms of action and clinical effectiveness of herbal treatments for disorders of gut-brain interaction

inferred← citeshttps://doi.org/10.1016/j.eclinm.2024.103024openalex-snapshot

Small intestinal bacterial overgrowth in chronic liver disease: an updated systematic review and meta-analysis of case-control studies

inferred← citeshttps://doi.org/10.1016/j.pop.2023.04.001openalex-snapshot

Gut Microbiome and Dietary Considerations

inferred← citeshttps://doi.org/10.1016/j.rgmx.2024.12.003openalex-snapshot

Recomendaciones de buena práctica clínica en el diagnóstico y tratamiento de la dispepsia funcional. Revisión de expertos de la Asociación Mexicana de Gastroenterología

inferred← citeshttps://doi.org/10.1016/j.rgmxen.2025.05.001openalex-snapshot

Good clinical practice recommendations for the diagnosis and treatment of functional dyspepsia: An expert review from the Asociación Mexicana de Gastroenterología

inferred← citeshttps://doi.org/10.1055/a-1729-0824openalex-snapshot

Funktionelle Dyspepsie

inferred← citeshttps://doi.org/10.1080/19490976.2022.2132078openalex-snapshot

The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celiac wheat sensitivity

inferred← citeshttps://doi.org/10.1080/19490976.2024.2413367openalex-snapshot

A pathophysiologic framework for the overlap of disorders of gut-brain interaction and the role of the gut microbiome

inferred← citeshttps://doi.org/10.1093/jcag/gwad046openalex-snapshot

Beyond Eosinophilic Esophagitis: Eosinophils in Gastrointestinal Disease—New Insights, “New” Diseases

inferred← citeshttps://doi.org/10.1097/mog.0000000000000928openalex-snapshot

Unravelling the controversy with small intestinal bacterial overgrowth

inferred← citeshttps://doi.org/10.1097/mog.0000000000001045openalex-snapshot

Current opinion: functional dyspepsia

inferred← citeshttps://doi.org/10.1097/mpg.0000000000003821openalex-snapshot

Validation of the Structured Assessment of Gastrointestinal Symptoms Scale to Support Standardized Evaluation and Follow‐up

inferred← citeshttps://doi.org/10.1111/nmo.14372openalex-snapshot

Role of the duodenal microbiota in functional dyspepsia

inferred← citeshttps://doi.org/10.1111/nmo.14866openalex-snapshot

A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut–brain interaction

inferred← citeshttps://doi.org/10.1136/gutjnl-2021-326158openalex-snapshot

Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia

inferred← citeshttps://doi.org/10.11569/wcjd.v34.i5.368openalex-snapshot

Liver cirrhosis and gastrointestinal motility disorders: From mechanisms to clinical practice

inferred← citeshttps://doi.org/10.14309/ajg.0000000000001764openalex-snapshot

Evidence-Based and Emerging Diet Recommendations for Small Bowel Disorders

inferred← citeshttps://doi.org/10.1515/biol-2022-0802openalex-snapshot

Clinical diagnosis, prevention, and treatment of neurodyspepsia syndrome using intelligent medicine

inferred← citeshttps://doi.org/10.21518/ms2026-354openalex-snapshot

Gastroesophageal reflux disease – functional dyspepsia overlap: From pathophysiological mechanisms to therapeutic strategy

inferred← citeshttps://doi.org/10.3389/fmicb.2024.1454910openalex-snapshot

The biogeography of the mucosa-associated microbiome in health and disease

inferred← citeshttps://doi.org/10.3389/fnins.2022.830356openalex-snapshot

Current and Future Approaches for Diagnosing Small Intestinal Dysbiosis in Patients With Symptoms of Functional Dyspepsia

inferred← citeshttps://doi.org/10.4103/jimr.jimr_23_23openalex-snapshot

How organic is “functional” dyspepsia?: Current understanding and approach to management

inferred← citeshttps://doi.org/10.5056/jnm22168openalex-snapshot

Small Intestinal Bacterial Overgrowth Complicating Gastrointestinal Manifestations of Systemic Sclerosis: A Systematic Review and Meta-analysis

inferred← citeshttps://doi.org/10.5662/wjm.v16.i1.107169openalex-snapshot

Exploring effectiveness of Metronidazole, Bismuth, and Rifaximin in treating small intestinal bacterial overgrowth and irritable bowel syndrome: A systematic review

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.